MMPs have potential as biomarkers for cancer diagnosis, prognosis, and treatment monitoring. Elevated levels of certain MMPs in blood, urine, or tissue samples can indicate the presence of cancer and its progression. For example, increased levels of MMP-9 have been correlated with poor prognosis in breast cancer patients. Ongoing research aims to validate MMPs as reliable biomarkers for various types of cancers.
